Published in J Neural Transm (Vienna) on February 26, 2008
Neuroprotective actions of brain aromatase. Front Neuroendocrinol (2009) 1.14
Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome. J Alzheimers Dis (2012) 0.87
Aromatase variants modify risk for Alzheimer's disease in a multiethnic female cohort. Dement Geriatr Cogn Disord (2013) 0.79
Intereleukin-10 promoter polymorphism in mild cognitive impairment and in its clinical evolution. Int J Alzheimers Dis (2010) 0.79
The sex-specific associations of the aromatase gene with Alzheimer's disease and its interaction with IL10 in the Epistasis Project. Eur J Hum Genet (2013) 0.78
Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis. Meta Gene (2016) 0.77
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Inflammation in neurodegenerative disease--a double-edged sword. Neuron (2002) 4.95
Interleukin-10 in the brain. Crit Rev Immunol (2001) 1.89
Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci U S A (2005) 1.67
Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience (2005) 1.38
Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet (2003) 1.26
Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology (2004) 1.15
The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology (2006) 1.13
Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines. J Neuroimmunol (2005) 1.10
Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging (2004) 1.06
Expression of CYP19 (aromatase) mRNA in different areas of the human brain. J Steroid Biochem Mol Biol (2000) 1.04
Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol Aging (2006) 1.00
Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun (2003) 0.96
CYP19 haplotypes increase risk for Alzheimer's disease. J Med Genet (2006) 0.91
Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. Dement Geriatr Cogn Disord (2005) 0.89
A common polymorphism in the 5'-untranslated region of the aromatase gene influences bone mass and fracture risk. Eur J Endocrinol (2004) 0.83
Age-related influence of common aromatase gene polymorphisms on bone mass of healthy men. Bone (2004) 0.78
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology (2006) 6.44
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Local and remote sustained trigger point therapy for exacerbations of chronic low back pain. A randomized, double-blind, controlled, multicenter trial. Spine (Phila Pa 1976) (1997) 2.29
[Agreement in the clinical diagnosis of pulmonary embolism]. Med Clin (Barc) (1998) 2.12
[Food sources and average intake of calcium in a representative sample of Spanish schoolchildren]. Nutr Hosp (2012) 2.09
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Absence of linkage of hereditary motor and sensory neuropathy type I to chromosome 1 markers. Genomics (1989) 2.00
Headache in type I Chiari malformation. Neurology (1992) 1.78
Isolated unilateral hypoglossal nerve palsy: nine cases. J Neurol (1998) 1.54
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology (2008) 1.53
Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53
Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. Brain (1991) 1.53
Olivopontocerebellar atrophy. A review of 117 cases. J Neurol Sci (1982) 1.51
Mutation rates at Y chromosome specific microsatellites. Hum Mutat (2005) 1.48
Acute motor conduction block neuropathy pattern occurring in the course of an acute inflammatory demyelinating polyradiculoneuropathy. Neurophysiol Clin (2008) 1.46
Isolated headache as the presenting clinical manifestation of intracranial tumors: a prospective study. Cephalalgia (1994) 1.44
[Risk factors and stroke among patients of different ages]. Rev Clin Esp (2003) 1.43
Assessment of the hypothalamic-pituitary-adrenal axis function after corticosteroid therapy for MS relapses. Acta Neurol Scand (1990) 1.40
The dose of propranolol for migraine prophylaxis. Efficacy of low doses. Cephalalgia (1989) 1.40
[Phosphocalcium metabolism disorders in patients with active pulmonary tuberculosis]. Med Clin (Barc) (1991) 1.39
Paraneoplastic myotonia. Muscle Nerve (1994) 1.39
Diagnostic approach to patients with suspected pulmonary embolism: a report from the real world. Postgrad Med J (1999) 1.38
[Epilepsy in Spain: comments concerning an unusual factor in decompensation]. Med Clin (Barc) (1991) 1.37
Basichondrocranium anomalies in adult Chiari type I malformation: a morphometric study. J Neurol Sci (1990) 1.37
Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine (Baltimore) (1995) 1.36
Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis. Ann Neurol (1990) 1.31
Linkage of hereditary motor and sensory neuropathy type I to the pericentromeric region of chromosome 17. Am J Hum Genet (1990) 1.30
Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J Med Genet (2005) 1.27
The alpha-synuclein gene in multiple system atrophy. J Neurol Neurosurg Psychiatry (2006) 1.25
Cephalic tetanus presenting with Bell's palsy. J Neurol Neurosurg Psychiatry (1985) 1.23
Diagnostic strategy for familial and sporadic cases of neuropathy associated with 17p11.2 deletion. Muscle Nerve (2001) 1.23
Cough, exertional, and sexual headaches: an analysis of 72 benign and symptomatic cases. Neurology (1996) 1.22
Seasonal deficiency of vitamin D in children: a potential target for osteoporosis-preventing strategies? J Bone Miner Res (1998) 1.22
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Hereditary "pure" spastic paraplegia: a study of nine families. J Neurol Neurosurg Psychiatry (1993) 1.20
Responsiveness of different rating instruments in spinocerebellar ataxia patients. Neurology (2010) 1.15
Immune thrombocytopenia caused by piperacillin/tazobactam. Clin Infect Dis (1998) 1.14
Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiol Dis (2000) 1.12
Familial cerebellar ataxia and hypogonadotropic hypogonadism: evidence for hypothalamic LHRH deficiency. J Neurol Neurosurg Psychiatry (1982) 1.12
Prognostic value of cytokines in SIRS general medical patients. Cytokine (2001) 1.10
Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group. Hum Genet (1999) 1.08
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol Scand (1987) 1.05
Missense polymorphisms of the WNT16 gene are associated with bone mass, hip geometry and fractures. Osteoporos Int (2013) 1.04
Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology (1998) 1.03
Botulism and pregnancy. Lancet (1996) 1.02
ANCA-associated pauci-immune crescentic glomerulonephritis complicating Sjögren's syndrome. Nephrol Dial Transplant (1996) 1.02
Low serum VEGF levels are associated with Alzheimer's disease. Acta Neurol Scand (2007) 1.00
SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia. Neurology (2008) 1.00
Lipid and lipoprotein metabolism in Hep G2 cells. Biochim Biophys Acta (1988) 0.99
Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatol (1995) 0.99
Neuroimaging diagnosis of Tolosa-Hunt syndrome: MRI contribution. Headache (1999) 0.98
Bone mass in young adults with Down syndrome. J Intellect Disabil Res (2008) 0.98
Wnt pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association study. Osteoporos Int (2009) 0.98
Craniocervical abnormalities in Down's syndrome. Dev Med Child Neurol (1983) 0.98
Peripheral motor and sensory nerve conduction studies in normal infants and children. Clin Neurophysiol (2000) 0.97
The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum Mol Genet (1995) 0.97
The distinctive headache of the occipital condyle syndrome: a report of four cases. Headache (1998) 0.97
Klotho gene polymorphism and male bone mass. Calcif Tissue Int (2007) 0.96
Guillain-Barré syndrome in Cantabria, Spain. An epidemiological and clinical study. Acta Neurol Scand (1994) 0.96
Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele. J Neurol (2005) 0.96
Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. Neuroendocrinology (2000) 0.96
A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other solid tumors. Ann Oncol (2009) 0.95
Primary brain lymphoma presenting as Parkinson's disease. Neuroradiology (2001) 0.95
Dysphagia in Chiari malformations. Neurology (1990) 0.95
Fatal familial insomnia: clinical, neuropathological, and genetic description of a Spanish family. J Neurol Neurosurg Psychiatry (2000) 0.95
Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease. J Neural Transm (Vienna) (2012) 0.95
CT findings in spinocerebellar degeneration. AJNR Am J Neuroradiol (1987) 0.95
False aneurysm formation after Salmonella virchow infection of a pre-existent ventricular aneurysm--survival after surgical resection. Postgrad Med J (1989) 0.94
Localized CNS brucellosis: report of 7 cases. Acta Neurol Scand (1988) 0.93
Erythromycin and the treatment of Coxiella burnetii pneumonia. J Antimicrob Chemother (1991) 0.93
Autoimmunity in Down's syndrome: another possible mechanism of Moyamoya disease. Stroke (1998) 0.92
Ageusia associated with thalamic plaque in multiple sclerosis. Eur Neurol (1994) 0.92
SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Clin Genet (2012) 0.91
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype. J Neurol Neurosurg Psychiatry (2007) 0.91
Brucellar arthritis in children and its successful treatment with trimethoprim-sulphamethoxazole (co-trimoxazole). Ann Rheum Dis (1986) 0.91
Retro-ocular headache with autonomic features resembling "continuous" cluster headache in lateral medullary infarction. J Neurol Neurosurg Psychiatry (2000) 0.90
Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Clinical, radiological and pathological features in eight cases. Brain (1983) 0.90
Motor neuron disease in Cantabria. Acta Neurol Scand (1988) 0.89
Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density. Horm Metab Res (2008) 0.89
Autosomal dominant cerebellar ataxias in Spain: molecular and clinical correlations, prevalence estimation and survival analysis. Acta Neurol Scand (2005) 0.88
Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3beta) and Alzheimer's disease risk. Acta Neurol Scand (2008) 0.88
Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease. Acta Neurol Scand (2009) 0.88
Vitamin D metabolism and serum binding proteins in anorexia nervosa. Bone (1991) 0.88